Aspen Neuroscience has expanded its ongoing Phase 1/2a clinical trial by dosing two new groups of Parkinson’s disease patients with sasineprocel (ANPD001). For the first time in the study, these participants received a new, commercial-ready formulation of the cell therapy designed to make future manufacturing and treatment…
Discussion
There are few things more humbling than confidently giving someone credit for a job they didn’t do. That’s what happened to my family when an Ikea table suddenly showed up, fully assembled, in my aunt’s living room. Naturally, we assumed one of my cousins had put it together while everyone…
Discussion
A European Medicines Agency (EMA) committee is recommending approval of Hopledo (IPX203) — an oral extended-release formulation of levodopa and carbidopa sold in the U.S. under the brand name Crexont — for people with Parkinson’s disease in the European Union who experience motor fluctuations despite treatment. The EMA’s…
Discussion
Almost every night during the warmer months, my husband, Arman, and I take a leisurely walk through our small neighborhood. It comprises just one street, and we have calculated that five laps around equals just over a mile. Since we both sit inside our house for hours, working all day,…
Discussion
Parkinson’s advocacy organizations are urging the newly established National Parkinson’s Project Advisory Council to move quickly to implement the project, a U.S. strategy to prevent, diagnose, treat, and ultimately cure Parkinson’s disease. The American Parkinson Disease Association (APDA), The Michael J. Fox Foundation for Parkinson’s Research (MJFF),…
Discussion
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has granted $2.74 million to X-tosis to support the preclinical development of XTS001, the company’s lead candidate for the treatment of Parkinson’s disease. The funding, granted through MJFF’s Parkinson’s Disease Therapeutics Pipeline Program, will support laboratory research…
Becoming educated and informed about Parkinson’s is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your Parkinson’s journey.
There is no cure for Parkinson’s yet, but there are treatments that can help manage the disease. Learn more about current therapeutic approaches here.
Get regular updates to your inbox.
